NorthStar Medical Radioisotopes has received two custom-built IBA Rhodotron TT 300-HE electron beam accelerators at its facility, the company announced recently. According to a release, the accelerators are critical components…

NorthStar Medical Radioisotopes and Ion Beam Applications (IBA), a provider of proton therapy solutions for the treatment of cancer, expanded its collaboration to increase the global availability of technetium-99m (Tc-99m),…

NorthStar Medical Radioisotopes is making organizational changes to drive focused growth for its therapeutic and specialized single photon emission computed tomography (SPECT) radioisotopes business, the company announced today. “NorthStar is…

NorthStar Medical Radioisotopes received approval from the U.S. Food and Drug Administration (FDA) to produce the isotope Molybdenum-99 (Mo-99) from concentrated Mo-98 (cMo-98), the company announced recently. “This approval of production…

NorthStar Medical Radioisotopes, along with Wilmette, Ill.-based Monopar Therapeautics, have partnered with IsoTherapeutics Group to develop and manufacture Radio-Immuno-Therapeutics (RITs) for the potential treatment of severe COVID-19, the company announced recently….

NorthStar Medical Radioisotopes is collaborating with Monopar Therapeutics, a clinical-stage biopharmaceutical company, to develop potential Radio-Immuno-Therapeutics (RITs) to treat severe COVID-19, the company announced recently. “NorthStar will apply its expertise…

NorthStar Medical Radioisotopes received approval from the U.S. Food and Drug Administration (FDA) the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Columbia, Mo., the company announced…

NorthStar Medical Radioisotopes and Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, have signed a letter of intent for the commercial supply of copper-67 as an…

NorthStar Medical Radioisotopes and Purdue University’s College of Pharmacy signed a collaborative agreement, which expands the College of Pharmacy’s nuclear pharmacy training program, the company announced recently. “We are excited…

NorthStar Medical Radioisotopes has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…